Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22010913 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting TB-IRIS NSAID Cox-2 Inhibitor Prevention Trial
Condition: Tuberculosis
Intervention: Drug: Meloxicam 7.5mg daily for 8 weeks

Indicates status has not been verified in more than two years